FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for KEPPRA (levetiracetam) from UCB, Inc., updating the product labeling as described in the submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Keppra (levetiracetam)

Snippet

SUPPL AP for KEPPRA (LEVETIRACETAM)